Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Banking · CIK 0001829576
$30.57
-0.42% · live
Updated
$675.1M market value
From Carter Bankshares, Inc.'s FY2025 10-K, filed Mar 5, 2026 · read the filing
Carter Bankshares takes deposits and lends money. It took in $20.3M last year, which makes it a small company. Of every dollar it sells, about 154 cents is left as profit.
The financial picture is led by profitability, with growth and debt worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by 3 insiders, not under a pre-arranged plan.
$169.5K sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Generally healthy, with a few things to watch.
From Carter Bankshares, Inc.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Profit margin
126.3% → 154.4%
Profit
$24.5M → $31.4M
Earnings per share
$1.06 → $1.42
Cash
$131.2M → $105.2M
Measured against FY2024, from the 10-K filed Mar 5, 2026
Improved: +28.1 pts
126.3% to 154.4%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
How the latest move compares (quote live), and what was published around it
CARE fell 0.42% on the latest quote. The average Financials company tracked here moved −1.33%, and the S&P 500 −0.47%. That is 0.9 points above its sector and in line with the market.
No filing from CARE and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 11 analysts covering this company, as of . Their views, not this site's.
Of 11 analysts publishing on this company, 3 say strong buy, 4 say buy and 4 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 154 cents of every dollar of sales as profit, earning $31.4M last year.
Slowly. Sales grew 4.6% last year.
For every $1 it owes, it owns $1.09 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it earned $31.4M and generated $39.9M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Mar 5, 2026Filing for FY2025 | FY202410-K · Mar 7, 2025Filing for FY2024 | FY202310-K · Mar 8, 2024Filing for FY2023 | FY202210-K · Mar 8, 2024Filing for FY2022 | FY202110-K · Mar 8, 2024Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $20.3M | $19.4M | $17.3M | $18.3M | $17.5M | +4.6% |
| Interest expense | — | — | $74.1M | $20.3M | $22.7M | — |
| Income before tax | $40.0M | $30.9M | $28.7M | $61.7M | $35.7M | +29.6% |
| Net income | $31.4M | $24.5M | $23.4M | $50.1M | $31.6M | +27.9% |
| Net marginNet income ÷ revenueWhat is this? | 154.4% | 126.3% | 135.4% | 273.4% | 180.7% | +28.1 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $1.42 | $1.06 | $1.02 | $2.09 | $1.20 | +33.6% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Sold on the open market — 1,000 shares at $31.25 ($31.3K)
Holds 16,856 shares after this filing.
Gifted shares — 280 shares at $35.16 ($9.8K)
Holds 16,921 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Reported another event
Read the filingReported another event
Read the filingWrite down why you are following Carter Bankshares, Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
Primary sources and further research
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from CARE's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Mar 5, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 6 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 7.3 | 6/6 | 10-K, filed Mar 5, 2026 |
| FY2024 | 7.3 | 6/6 | 10-K, filed Mar 7, 2025 |
| FY2023 | 6.0 | 4/6 | 10-K, filed Mar 8, 2024 |
| FY2022 | 6.0 | 5/6 | 10-K, filed Mar 10, 2023 |
| FY2021 | 7.3 | 6/6 | 10-K, filed Mar 11, 2022 |
| FY2020 | 6.0 | 3/4 | 10-K, filed Mar 11, 2022 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
6 of 6 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 3 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +27.9%
$24.5M to $31.4MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +33.6%
$1.06 to $1.42Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -19.8%
$131.2M to $105.2MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +10.4%
$28.8M to $31.8MNotable
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: -4.3%
23.1M to 22.1MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 6, 2026 — read it.
Improved: +239.7%
$8.5M to $28.9MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +247.5%
$0.38 to $1.30Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +176.8%
$99.9M to $276.5MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -2.2%
22.7M to 22.2MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 6, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: -66.3%
$85.8M to $28.9MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: -66.3%
$3.87 to $1.30Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +21.1%
$228.3M to $276.5MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 12.0% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 5.2x — investors pay $5.2 for each $1 of trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Sold on the open market — 2,500 shares at $34.54 ($86.3K)
Holds 33,242 shares after this filing.
Sold on the open market — 1,500 shares at $34.60 ($51.9K)
Holds 55,000 shares after this filing.
Was granted or awarded shares — 5,005 shares
Holds 31,798 shares after this filing.
Was granted or awarded shares — 3,240 shares
Holds 16,302 shares after this filing.
Was granted or awarded shares — 8,649 shares
Holds 35,742 shares after this filing.
Was granted or awarded shares — 12,300 shares
Holds 79,767 shares after this filing.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Quarterly report for Q2 FY2026
Profit +239.7% · Earnings per share +247.5% · Cash +176.8% — against Q2 FY2025
Made a Regulation FD disclosure
Read the filingReported another event
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingMade a Regulation FD disclosure
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Profit +857.9% · Free cash flow +6130.7% · Earnings per share +901.2% — against Q1 FY2025
Read the filingMade a Regulation FD disclosure
Read the filingReported another event
Read the filingReported another event
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingReported another event
Read the filingAnnual report for FY2025
Profit margin +28.1 pts · Profit +27.9% · Earnings per share +33.6% — against FY2024
Read the filingReported another event
Read the filingMade a Regulation FD disclosure
Read the filingPublished results
Read the filing